132 related articles for article (PubMed ID: 9490236)
1. Prevention of restenosis after angioplasty in small coronary arteries with probucol.
Rodés J; Côté G; Lespérance J; Bourassa MG; Doucet S; Bilodeau L; Bertrand OF; Harel F; Gallo R; Tardif JC
Circulation; 1998 Feb; 97(5):429-36. PubMed ID: 9490236
[TBL] [Abstract][Full Text] [Related]
2. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P
N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125
[TBL] [Abstract][Full Text] [Related]
3. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
[TBL] [Abstract][Full Text] [Related]
5. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group.
Côté G; Tardif JC; Lespérance J; Lambert J; Bourassa M; Bonan R; Gosselin G; Joyal M; Tanguay JF; Nattel S; Gallo R; Crépeau J
Circulation; 1999 Jan 5-12; 99(1):30-5. PubMed ID: 9884376
[TBL] [Abstract][Full Text] [Related]
6. Effects of AGI-1067 and probucol after percutaneous coronary interventions.
Tardif JC; Grégoire J; Schwartz L; Title L; Laramée L; Reeves F; Lespérance J; Bourassa MG; L'Allier PL; Glass M; Lambert J; Guertin MC;
Circulation; 2003 Feb; 107(4):552-8. PubMed ID: 12566365
[TBL] [Abstract][Full Text] [Related]
7. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
[TBL] [Abstract][Full Text] [Related]
8. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.
Sirtori CR; Franceschini G
N Engl J Med; 1997 Dec; 337(26):1918; author reply 1919. PubMed ID: 9417525
[No Abstract] [Full Text] [Related]
9. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
O'Keefe JH; Stone GW; McCallister BD; Maddex C; Ligon R; Kacich RL; Kahn J; Cavero PG; Hartzler GO; McCallister BD
Am J Cardiol; 1996 Mar; 77(8):649-52. PubMed ID: 8610621
[TBL] [Abstract][Full Text] [Related]
10. Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis.
Sekiya M; Funada J; Watanabe K; Miyagawa M; Akutsu H
Am J Cardiol; 1998 Jul; 82(2):144-7. PubMed ID: 9678282
[TBL] [Abstract][Full Text] [Related]
11. Prevention of restenosis with antioxidants: mechanisms and implications.
Tardif JC; Grégoire J; L'Allier PL
Am J Cardiovasc Drugs; 2002; 2(5):323-34. PubMed ID: 14727962
[TBL] [Abstract][Full Text] [Related]
12. Effects of plaque composition on vascular remodelling after angioplasty in the MultiVitamins and Probucol (MVP) trial.
Lee HS; Tardif JC; Harel F; Côté G; Joyal M; Gosselin G; L'Allier PL; Doucet S; de Guise P; Lespérance J; Grégoire JC; Couturier A
Can J Cardiol; 2002 Mar; 18(3):271-5. PubMed ID: 11907616
[TBL] [Abstract][Full Text] [Related]
13. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).
Daida H; Kuwabara Y; Yokoi H; Nishikawa H; Takatsu F; Nakata Y; Kutsumi Y; Oshima S; Nishiyama S; Ishiwata S; Kato K; Nishimura S; Miyauchi K; Kanoh T; Yamaguchi H
Am J Cardiol; 2000 Sep; 86(5):550-2, A9. PubMed ID: 11009277
[TBL] [Abstract][Full Text] [Related]
14. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis.
Schneider JE; Berk BC; Gravanis MB; Santoian EC; Cipolla GD; Tarazona N; Lassegue B; King SB
Circulation; 1993 Aug; 88(2):628-37. PubMed ID: 8339427
[TBL] [Abstract][Full Text] [Related]
15. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.
Jay SJ
N Engl J Med; 1997 Dec; 337(26):1918-9; author reply 1919. PubMed ID: 9417526
[No Abstract] [Full Text] [Related]
16. Vessel size, antioxidants, and restenosis: never too small, not too little, but often too late.
Edelman ER
Circulation; 1998 Feb; 97(5):416-20. PubMed ID: 9490233
[No Abstract] [Full Text] [Related]
17. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
[TBL] [Abstract][Full Text] [Related]
18. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Tardif JC; Grégoire J; Lavoie MA; L'Allier PL
Curr Opin Lipidol; 2003 Dec; 14(6):615-20. PubMed ID: 14624139
[TBL] [Abstract][Full Text] [Related]
20. Low daily dose of antioxidant probucol decreases incidence and severity of restenosis after transluminal coronary balloon angioplasty.
Kaminnyi AI; Lankin VZ; Samko AN; Sozykin AL; Provatorov SI; Konovalova GG; Perepelitsa EI; Tikhaze AK; Polevaya TY; Kukharchuk VV; Belenkov YN
Bull Exp Biol Med; 2005 Feb; 139(2):183-5. PubMed ID: 16027801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
